Skip to main content

Animations

MJFF Publications

3211 - 3220 of 6310 Results
Title
Year
  • Year
  • 2013
  • 2018
  • 2019
  • 2012
  • 2017
  • 2018
  • 2015
  • 2017
  • 2019
  • 2018
  • Summary Details
    OPEN
    Title: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00177
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Altered dynamics of visual contextual interactions in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0085-5
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's Disease
    Journal Name: STEM CELLS
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/stem.1060
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1616874114
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1337-8
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Is the MC1R variant p.R160W associated with Parkinson's?
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24527
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27232
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005
    Citation Count: 61
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.